Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

BF Haynes, K Wiehe, P Borrow, KO Saunders… - Nature Reviews …, 2023 - nature.com
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive.
There are many reasons why the development of a potent and durable HIV-1 vaccine is …

[HTML][HTML] Germinal center B cell dynamics

L Mesin, J Ersching, GD Victora - Immunity, 2016 - cell.com
Germinal centers (GCs) are the site of antibody diversification and affinity maturation and as
such are vitally important for humoral immunity. The study of GC biology has undergone a …

COVID-19 infection: implications for perioperative and critical care physicians

JR Greenland, MD Michelow, L Wang… - …, 2020 - pmc.ncbi.nlm.nih.gov
Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19),
an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome …

FUBAR: a fast, unconstrained bayesian approximation for inferring selection

B Murrell, S Moola, A Mabona, T Weighill… - Molecular biology …, 2013 - academic.oup.com
Abstract Model-based analyses of natural selection often categorize sites into a relatively
small number of site classes. Forcing each site to belong to one of these classes places …

Human circulating PD-1+ CXCR3− CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses

M Locci, C Havenar-Daughton, E Landais, J Wu… - Immunity, 2013 - cell.com
The vast majority of currently licensed human vaccines work on the basis of long-term
protective antibody responses. It is now conceivable that an antibody-dependent HIV …

[HTML][HTML] Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting

L Mesin, A Schiepers, J Ersching, A Barbulescu… - Cell, 2020 - cell.com
Repeated exposure to pathogens or their antigens triggers anamnestic antibody responses
that are higher in magnitude and affinity than the primary response. These involve …

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

NA Doria-Rose, CA Schramm, J Gorman, PL Moore… - Nature, 2014 - nature.com
Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the
HIV-1 envelope, but the mechanism of their elicitation has been unclear. Here we define the …

Rational HIV immunogen design to target specific germline B cell receptors

J Jardine, JP Julien, S Menis, T Ota, O Kalyuzhniy… - Science, 2013 - science.org
Vaccine development to induce broadly neutralizing antibodies (bNAbs) against HIV-1 is a
global health priority. Potent VRC01-class bNAbs against the CD4 binding site of HIV gp120 …

The promise and challenge of high-throughput sequencing of the antibody repertoire

G Georgiou, GC Ippolito, J Beausang, CE Busse… - Nature …, 2014 - nature.com
Efforts to determine the antibody repertoire encoded by B cells in the blood or lymphoid
organs using high-throughput DNA sequencing technologies have been advancing at an …

Immune clearance of highly pathogenic SIV infection

SG Hansen, MP Jr, AB Ventura, CM Hughes… - Nature, 2013 - nature.com
Established infections with the human and simian immunodeficiency viruses (HIV and SIV,
respectively) are thought to be permanent with even the most effective immune responses …